Kaleab Mekonnen, is a
Case Manager/care Coordinator based in Los Angeles, California. Kaleab Mekonnen is licensed to practice in * (Not Available) (license number ) and his current practice location is
470 E 3rd St Ste C, Los Angeles, California. He can be reached at his office (for appointments etc.) via phone at
(213) 620-5712.
NPI number for Kaleab Mekonnen is 1881160331 and his current mailing address is 470 E 3rd St Ste C, Los Angeles, California. He
does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1881160331.
Healthcare Provider's Profile
Full Name | Kaleab Mekonnen |
---|
Gender | Male |
---|
Speciality | Case Manager/care Coordinator |
---|
Location | 470 E 3rd St Ste C, Los Angeles, California |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
NPI Data:
- NPI Number: 1881160331
- Provider Enumeration Date: 10/22/2018
- Last Update Date: 10/24/2018
Medical Identifiers
Medical identifiers for Kaleab Mekonnen such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1881160331 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
101Y00000X | Counselor | (* (Not Available)) | Secondary |
171M00000X | Case Manager/care Coordinator | (* (Not Available)) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kaleab Mekonnen is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Kaleab Mekonnen, 470 E 3rd St Ste C, Los Angeles, CA 90013-1630 Ph: (213) 620-5712 | Kaleab Mekonnen, 470 E 3rd St Ste C, Los Angeles, CA 90013-1630 Ph: (213) 620-5712 |
Reviews and Comments